Found: 19
Select item for more details and to access through your institution.
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 669, doi. 10.1007/s00432-015-2033-z
- By:
- Publication type:
- Article
Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 679, doi. 10.3390/jpm12050679
- By:
- Publication type:
- Article
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 190, n. 1, p. 103, doi. 10.1007/s10549-021-06371-9
- By:
- Publication type:
- Article
Effects of ALL- trans-retinoic acid and 13- cis-retinoic acid on breast-cancer cell lines: Growth inhibition and apoptosis induction.
- Published in:
- International Journal of Cancer, 1997, v. 70, n. 5, p. 619, doi. 10.1002/(SICI)1097-0215(19970304)70:5<619::AID-IJC21>3.0.CO;2-6
- By:
- Publication type:
- Article
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987651
- By:
- Publication type:
- Article
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987651
- By:
- Publication type:
- Article
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920958355
- By:
- Publication type:
- Article
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 1, p. 8, doi. 10.1159/000481098
- By:
- Publication type:
- Article
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy).
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2941, doi. 10.3390/cancers12102941
- By:
- Publication type:
- Article
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919833864
- By:
- Publication type:
- Article
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919833864
- By:
- Publication type:
- Article
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 3, p. 209, doi. 10.1177/1758834016639873
- By:
- Publication type:
- Article
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 6, p. 334, doi. 10.1177/1758834013508197
- By:
- Publication type:
- Article
F-Fluoride PET/CT in the detection of bone metastases in clear cell renal cell carcinoma: discordance with bone scintigraphy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 12, p. 1930, doi. 10.1007/s00259-013-2508-6
- By:
- Publication type:
- Article
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 2189, doi. 10.2147/DDDT.S79563
- By:
- Publication type:
- Article
Identification of a Panel of miRNAs Associated with Resistance to Palbociclib and Endocrine Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1498, doi. 10.3390/ijms25031498
- By:
- Publication type:
- Article